Edition:
United Kingdom

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

16.55USD
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
$16.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
83,200
52-wk High
$20.55
52-wk Low
$7.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.686
FY 2017 Dec '17 0.00 -0.925
Sep '17 0.30 -0.684
Jun '17 0.30 -0.660
Mar '17 0.30 -0.668
FY 2016 Dec '16 0.30 -0.560
Sep '16 0.30 -0.557
Jun '16 0.24 -0.524
Mar '16 0.21 -0.511
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 0.04 0.20 0.00 --
Quarter Ending Sep-18 5 0.04 0.20 0.00 --
Year Ending Dec-18 5 0.49 2.46 0.00 29.48
Year Ending Dec-19 5 62.58 135.00 4.97 54.61
Earnings (per share)
Quarter Ending Jun-18 5 -0.64 -0.61 -0.69 --
Quarter Ending Sep-18 5 -0.67 -0.61 -0.74 --
Year Ending Dec-18 5 -2.73 -2.52 -2.92 -1.01
Year Ending Dec-19 5 -0.62 1.54 -2.57 -0.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 82.81 32.74
P/E High - Last 5 Yrs. -- 289.15 45.73
P/E Low - Last 5 Yrs. -- 90.24 24.23
Beta -0.12 0.91 0.88
Price to Sales (TTM) 252.25 109.18 5.71
Price to Book (MRQ) 3.76 13.44 5.37
Price to Tangible Book (MRQ) 3.78 13.96 6.94
Price to Cash Flow (TTM) -- 70.39 23.32
% Owned Institutions 49.44 13.84 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.50
Dividend Yield - 5 Year Avg -- 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) -- 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 26.38 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago 40.26 77.35 5.68
Sales - 5 Yr. Growth Rate -- 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -25.96 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago -14.13 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate -- 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.83 2.19
Current Ratio (MRQ) 4.65 5.26 2.98
LT Debt to Equity (MRQ) 0.00 24.54 12.19
Total Debt to Equity (MRQ) 0.00 26.17 16.46
Interest Coverage (TTM) -- -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.81 54.46
Gross Margin - 5 Yr. Avg. -- 51.76 52.22
EBITD Margin (TTM) -4,219.92 -- --
EBITD - 5 Yr. Avg -6,446.46 -564.12 10.98
Operating Margin (TTM) -4,220.23 -706.11 4.74
Operating Margin - 5 Yr. Avg. -6,468.54 -585.15 6.41
Pre-Tax Margin (TTM) -4,171.16 -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -6,417.04 -588.45 6.83
Net Profit Margin (TTM) -4,171.28 -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -6,415.84 -591.46 3.10
Effective Tax Rate (TTM) -- 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,297 22,312,275 846,855,748
Net Income/Employee (TTM) -1,722,596 2,947,385 99,619,396
Receivable Turnover (TTM) 19.87 19.92 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.01 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.70 -0.70 10.95
Return on Assets - 5 Yr. Avg. -47.10 -0.06 12.32
Return on Investment (TTM) -65.15 2.00 14.38
Return on Investment - 5 Yr. Avg. -52.69 2.81 16.11
Return on Equity (TTM) -65.34 3.49 16.08
Return on Equity - 5 Yr. Avg. -53.70 4.33 17.41
  1 Year 3 Year 5 Year
Sales % 59.19 144.78 --
EPS (TTM) % 0.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Stemline Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.35%
# of Holders: 125
Total Shares Held: 20,691,664
3 Mo. Net Change: 5,348,845
# New Positions: 20
# Closed Positions: 17
# Increased Positions: 63
# Reduced Positions: 40
# Net Buyers: 23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.